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Shiga toxin (Stxs) is a family of structurally and functionally related bacterial cytotoxins
produced by Shigella dysenteriae serotype 1 and shigatoxigenic group of Escherichia
coli that cause shigellosis and hemorrhagic colitis, respectively. Until recently, it has
been thought that Stxs only inhibits the protein synthesis and induces expression to
a limited number of genes in host cells, but recent data showed that Stxs can trigger
several signaling pathways in mammalian cells and activate cell cycle and apoptosis.
To explore the changes in gene expression induced by Stxs that have been shown
in other systems to correlate with cancer progression, we performed the simulated
analysis of cDNA dataset and found differentially expressed genes (DEGs) of human
THP1-monocytic cells treated with Stxs. In this study, the entire data (treated and
untreated replicates) was analyzed by statistical algorithms implemented in Bioconductor
packages. The output data was validated by the k-fold cross technique using generalized
linear Gaussian models. A total of 50 DEGs were identified. 7 genes including TSLP, IL6,
GBP1, CD274, TNFSF13B, OASL, and PNPLA3 were considerably (<0.00005) related to
cancer proliferation. The functional enrichment analysis showed 6 down-regulated and
1 up-regulated genes. Among these DEGs, IL6 was associated with several cancers,
especially with leukemia, lymphoma, lungs, liver and breast cancers. The predicted
regulatory motifs of these genes include conserved RELA, STATI, IRFI, NF-kappaB,
PEND, HLF, REL, CEBPA, DI_2, and NFKB1 transcription factor binding sites (TFBS)
involved in the complex biological functions. Thus, our findings suggest that Stxs has the
potential as a valuable tool for better understanding of treatment strategies for several
cancers.
Keywords: cDNA dataset, Shiga toxin, differential expression, cancers, enrichment analysis, TFBS
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INTRODUCTION

The expression profiling of treated and untreated THP-1
cells verifies that Stxs are responsible for genetic alterations
(Leyva-Illades et al., 2010). Studies show that Stxs is associated
with an elevated secretion of cytokines and other chemical
mediators responsible for numerous diseases including cancer
(DesRochers et al., 2015; Hattori et al., 2016). E. coli producing
Stxs was isolated from cancer and diarrheagenic individuals
(Chao et al., 2017). It has been observed that Stxs significantly
caused increased expression of GRO, G-CSF, IL-1β, IL-8, and
TNFα in THP-1 like cells with an increased level of proinflammatory cytokines and chemokines causing several diseases
(Brandelli et al., 2015). The exact mechanism of influence of gene
expression by Stxs as well as the functions of these influenced
genes in respect to pathophysiology and molecular biology
of cancer development have not been completely understood
(Tesh, 2010). In this regard, cDNA microarray technology
is a valuable tool to discover differential gene expression.
The accumulated data from gene expression studies in public
repositories provides an opportunity to construct pooled gene
expression data sets from a larger number of individuals.
In this study, we performed cDNA differential analysis of
the publicly available dataset to discover the DEGs and to
further explore the transcriptional responses of human THP1monocytic cells affected by bacterial Stxs. We uncovered the
aberrantly expressed genes which are significantly linked to
cancer. We also report the analysis of the pathophysiological
pathways and predicted potential regulatory motif of these
genes.

Shiga toxins (Stxs) are bacterial cytotoxins mainly produced
by enteric pathogens. It is a family of related toxins with two
major groups, Stx1 and Stx2, encoded by genes belonging to
the lambdoid prophages genome (Friedman and Court, 2001).
The sources of Stxs includes Shigella dysenteriae, the Shiga
toxigenic group of Escherichia coli (STEC) including serotypes
O157:H7, O104:H4, and other enterohemorrhagic E. coli (EHEC)
(Beutin, 2006; Spears et al., 2006) responsible for millions of cases
of severe dysentery, food poisoning, gastroenteritis and bowel
necrosis (Mims et al., 1993; Vogt and Dippold, 2005; Todar, 2007;
World Health Organization, 2016), and this situation is worse in
underdeveloped countries.
The Stxs are capable to cross epithelial, endothelial, leukocytic,
lymphoid and other neuronal cells through transcytotic or
paracellular mechanisms (Malyukova et al., 2009), may then
associate with blood monocytes, macrophages and neutrophils
to circulate the bloodstream and bind to toxin-binding
glycosphingolipid Gb3 receptor by clathrin-dependent or
clathrin-independent mechanisms (Lingwood, 2003; Schweppe
et al., 2008). After internalization, the toxins undergo retrograde
intracellular flow to reach the endoplasmic reticulum (Sandvig
et al., 2002). Importantly, the toxin receptor, Gb3, has a limited
expression in normal tissues but is overexpressed in several types
of cancer and besides apoptosis, may cause “apoptosis induced
proliferation” (Torgersen et al., 2010). Stxs are cytotoxic proteins
that enter the host cell via macropinosome and function as an
N-glycosidase, cleave a specific adenine nucleobase from the 28S
RNA of the 60S subunit of the ribosome, thereby halting host
cell protein synthesis (Sandvig et al., 2010; Lukyanenko et al.,
2011). This activity of the toxin resides in the A subunit and the
pentamer of similar B subunit intercedes toxin binding to the Gb3
(Fraser et al., 1994; Lingwood et al., 2010; Melton-Celsa, 2014).
These toxins can also activate host cell’s signaling pathways and
trigger apoptosis in many cell types. They induce apoptosis of
epithelial, endothelial, leukocytic, lymphoid and neuronal cells
(Tesh, 2010). After activation, the interleukin-1 (IL-1) and tumor
necrosis factor alpha (TNF-α) sensitize endothelial cells to the
action of Stx in vitro by increasing Gb3 expression (van de
Kar et al., 1992; Stricklett et al., 2002). Upon sensitization, the
innate immune response stimulated by Stxs may contribute to
the development of vascular lesions (Ramegowda et al., 1999).
It has been reported that when human monocytic THP-1 cells
are treated with Stxs, they secrete tumor necrosis factor alpha
(TNF-α)-, interleukin-1 (IL-1), and interleukin-6 (IL-6), which
further alter the expression of these cytokines and chemokines
(Leyva-Illades et al., 2010). Transcriptional regulation involves
prolonged activation of stress-associated protein kinases JNK (cJun N-terminal kinases) and p38, extracellular signal-activated
kinase1/2 (ERK1/2), and activation of transcription factors NFkappaB (NF-κB) (nuclear factor) (Thorpe et al., 2001; Harrison
et al., 2005). Recent evidence indicates that signaling through
MAPK pathways and proapoptotic proteins -mostly caspasescan induce proliferation of neighboring surviving cells to replace
apoptotic and dying cells. This “apoptosis induced proliferation”
is critical for tissues regeneration and cancer progression (Tesh,
2010; Ryoo and Bergmann, 2012).
Frontiers in Microbiology | www.frontiersin.org

MATERIALS AND METHODS
Accession of cDNA Dataset
The goal of this study was to identify aberrantly expressed
cancer-related genes in the human THP1-monocytic cells lines
affected by bacterial Shiga toxins (Supplementary Figure 1).
We acquired the cDNA microarray dataset (NCBI, 2015)
GSE19315 (Leyva-Illades et al., 2010) from Gene Expression
Omnibus database (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE19315)1 . This dataset examined the transcriptional
changes in human THP-1 cells to Stxs toxins. It was performed
by taking three untreated (controls) and six treated replicates
(samples) followed by the real-time studies. The Stxs changed
the genetic expression which is associated with the increased
production of cytokines and other proinflammatory mediators.
The GPL570 [HG-U133_Plus_2] Affymetrix Human Genome
U133 Plus 2.0 Array (Affymetrix, Inc., Santa Clara, CA, 95051,
USA, Technology: in situ oligonucleotide) platform was used, and
the Annotation information (hgu133plus2) of probes was used to
detect the gene expression.

Normalization and Identification of
Differentially Expressed Genes (DEGs)
Pheno-data files of this dataset were prepared in identifiable
format and missing values imputed (Troyanskaya et al., 2001).
The Bioconductor packages including ArrayQuality Metrics on
1 Gene Expression Omnibus: http://www.ncbi.nlm.nih.gov/geo/. Accessed 201605.25.
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FIGURE 1 | Normalization and analysis of array quality metrics (A) Box-plot representing summaries of the signal intensity distributions of the arrays. Each box
corresponds to one array. Outlier detection was performed by computing the Kolmogorov-Smirnov statistic Ka between each array’s distribution and the distribution
of the pooled data (B) Heatmap of the distances between arrays. The color scale is chosen to cover the range of distances encountered in the dataset (C) Histogram
representing expression after normalization (D) MA plots. M and A are defined as: M = log2 (I1 ) – log2 (I2 ), A = 1/2 (log2 (I1 )+log2 (I2 )), where I1 is the intensity of the
array studied, and I2 is the intensity of a “pseudo”-array that consists of the median across arrays.

TABLE 1 | A summary statistic for each array in the batch, assessing the severity
of RNA degradation and significance level.

′

FIGURE 2 | Side-by-side plot produced by plotAffyRNAdeg representing 5 -3
trend to assess the severity of degradation of RNA and significance level.
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S. no

Arrays/Samples

Slope

1

GSM479983.CEL

1.01000

0.00109

2

GSM479984.CEL

1.000000

0.000827
1.15e-05

P-value

3

GSM479985.CEL

1.41e+00

4

GSM479986.CEL

0.6570

0.0183

5

GSM479987.CEL

1.18000

0.00033

6

GSM479988.CEL

1.10e+00

9.65e-05

7

GSM479989.CEL

0.91700

0.00196

8

GSM479990.CEL

0.97500

0.00112

9

GSM479991.CEL

1.40e+00

1.32e-05

R version 3.1.3 were used to execute the preprocessing steps of
normalization and quality control (Bolstad et al., 2003; Fujita
et al., 2006; Obenchain et al., 2014). Robust Multi-array Analysis
(RMA) was used to adjust the background and normalization
(Yoon et al., 2004) for perfect matches (PM) and mismatches
(MM) in order to get a summary of intensities (summary

′
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TABLE 2 | List of 50-differentially expressed genes.
S. no

Probe ID

Gene ID

logFC

t

P-value

adj.P.Val

B

1

240287_at

irg1

−5.93568

−50.392

7.88E-12

2.30E-07

14.35412

2

235737_at

TSLP

−5.81414

−50.0105

8.41E-12

2.30E-07

14.33257

3

235574_at

GBP4

−4.36184

−40.5895

4.93E-11

8.98E-07

13.64744

4

205207_at

IL6

−5.18603

−37.197

1.03E-10

1.41E-06

13.30453

5

202510_s_at

TNFAIP2

−4.1804

−34.7333

1.84E-10

2.01E-06

13.01096

6

202269_x_at

GBP1

−3.20432

−33.4148

2.55E-10

2.32E-06

12.83562

7

227458_at

CD274

−5.57009

−31.9417

3.73E-10

2.91E-06

12.62265

8

223501_at

TNFSF13B

−4.88682

−31.3969

4.31E-10

2.95E-06

12.53892

9

210797_s_at

OASL

−4.56379

−29.9747

6.38E-10

3.87E-06

12.3066

10

214038_at

ccl8

−6.57392

−28.3084

1.03E-09

5.65E-06

12.00654

11

205013_s_at

Adora2a

−3.81754

−27.4662

1.33E-09

6.62E-06

11.84223

12

205569_at

LAMP3

−6.29062

−26.5359

1.78E-09

8.03E-06

11.64986

13

229450_at

Ifit3

−4.28387

−26.3161

1.91E-09

8.03E-06

11.60267

14

222793_at

DDX58

−4.25905

−25.5566

2.44E-09

8.71E-06

11.43411

15

218810_at

ZC3H12A

−2.84809

−25.299

2.66E-09

8.71E-06

11.37495

16

205660_at

OASL

−4.97761

−25.0953

2.84E-09

8.71E-06

11.32745

17

202688_at

TNFSF10

−5.15206

−25.0718

2.87E-09

8.71E-06

11.32192

18

205599_at

Traf1

−4.14304

−24.8005

3.14E-09

8.87E-06

11.2575

19

204747_at

Ifit3

−4.25172

−24.7046

3.25E-09

8.87E-06

11.23446

20

219716_at

APOL6

−2.70983

−24.2599

3.78E-09

9.53E-06

11.12554

21

202759_s_at

akap2/PALM2

−2.47769

−24.2173

3.84E-09

9.53E-06

11.11493

22

230036_at

SAMD9L

−2.94113

−22.691

6.62E-09

1.57E-05

10.71328

23

235643_at

SAMD9L

−3.19263

−22.0591

8.39E-09

1.84E-05

10.53392

24

223502_s_at

TNFSF13B

−5.13985

−21.8857

8.96E-09

1.84E-05

10.48325

25

205992_s_at

IL15

−4.10568

−21.8596

9.05E-09

1.84E-05

10.47556

26

209038_s_at

EHD1

−3.57268

−21.8496

9.09E-09

1.84E-05

10.47261

27

209037_s_at

EHD1

−4.10382

−21.4847

1.05E-08

2.04E-05

10.36366

28

242752_at

–

−2.33834

−21.2349

1.15E-08

2.08E-05

10.28736

29

226757_at

Ifit2

−5.22852

−21.224

1.16E-08

2.08E-05

10.28402

30

231577_s_at

GBP1

−2.98548

−21.1802

1.18E-08

2.08E-05

10.27046

31

206157_at

Ptx3

−3.72465

−20.8941

1.32E-08

2.19E-05

10.18102

32

208012_x_at

SP110

−2.34041

−20.8471

1.35E-08

2.19E-05

10.16617

33

202760_s_at

akap2/PALM2

−3.0481

−20.8187

1.36E-08

2.19E-05

10.15714

34

218943_s_at

DDX58

−4.97703

−20.6726

1.44E-08

2.25E-05

10.11048

35

202086_at

mx1

−3.63011

−19.9264

1.96E-08

2.98E-05

9.864092

36

225344_at

NCOA7

−2.6496

−19.8461

2.03E-08

3.00E-05

9.836755

37

215495_s_at

samd4a

−1.78695

−19.4961

2.35E-08

3.39E-05

9.715643

38

220104_at

ZC3HAV1

−3.4764

−19.3094

2.55E-08

3.57E-05

9.649722

39

210029_at

IDO1

−6.46305

−19.2265

2.64E-08

3.61E-05

9.620158

40

211122_s_at

CXCL11

−7.63526

−19.0851

2.81E-08

3.75E-05

9.569288

41

1557905_s_at

CD44

−2.72423

−18.8999

3.05E-08

3.88E-05

9.501801

42

1555464_at

IFIH1

−4.11661

−18.8975

3.05E-08

3.88E-05

9.500928

43

229221_at

CD44

−3.80452

−18.6478

3.41E-08

4.16E-05

9.408394

44

210163_at

CXCL11

−6.82817

−18.6392

3.42E-08

4.16E-05

9.405188

45

209723_at

SERPINB9

−4.33364

−18.5564

3.55E-08

4.22E-05

9.37409

46

204103_at

CCL4

−4.92524

−18.3405

3.91E-08

4.55E-05

9.292083

47

214329_x_at

TNFSF10

−5.31551

−18.2625

4.05E-08

4.57E-05

9.262101

48

203915_at

Cxcl9

−4.43103

−18.2429

4.09E-08

4.57E-05

9.254554

−2.59583

−18.1602

4.25E-08

4.65E-05

9.22254

2.38E-09

8.71E-06

11.45275

49

210285_x_at

WTAP

50

220675_s_at

pnpla3

Frontiers in Microbiology | www.frontiersin.org

2.423905

25.63874

4

Aberration
Down-regulated

Up-regulated
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measured. The moderated statistics were calculated; genes were
ranked with respect to the resulting scores and p-values. A false
discovery rate (FDR) less than 0.05, p ≤ 0.05, Average Expression
Level (AEL) ≥40% and an absolute log fold change (logFC)
greater than 1 were set as the significant cutoffs.

statistic). To assess the quality of RNA in samples, AffyRNAdeg,
summaryAffyRNAdeg, and plotAffyRNAdeg Bioconductor
packages were used for degradation analysis (Affymetrix, 1999,
2001). After normalization, we performed the relative study and
identified differentially expressed genes by pairwise comparison
from genomic experiments (Tusher et al., 2001) and multiple
testing corrections were completed by Benjamini-Hochberg
method (Benjamini and Hochberg, 1995). The Bioconductor
package LIMMA, a modified statistic that is proportional to the
statistic with sample variance offsets, was used to shortlist the
DEGs. By this package, duplicate spots and quality weights were

K-Fold Cross Validation
We used the k-fold technique (Seymour, 1993) to validate the
shortlisted differentially expressed genes using the Bioconductor
“boot” package (Ripley, 2010). Bootstrapping can be helpful
to correct some of the bias associated with the analysis.
The generalized linear models (Gaussian) were applied and
the “cv.glm” function was used to assess the k-fold cross
validation for these cases. This function, firstly, predicts the
error of the raw cross-validation followed by the adjusted
cross validation estimation. The Gaussian function was trailed
by the complete Leave-One-Out-Cross-Validation (LOOCV)
procedure. The LOOCV method is instinctively named as one
case is left out as the testing set and the rest of the data are used
as the training set (Ripley, 2010).

TABLE 3 | k-fold cross validation by bioconductor “boot” package using
dispersion parameter of Gaussian family.
Estimate

Std. Error

t-value

(Intercept)

0.023823

0.003194

7.46*

8.81E−14 ***

x1

0.349441

0.00554

63.071

< 2.00E−16 ***

x2

0.078029

0.00486

16.056

< 2.00E−16 ***

x3

0.150248

0.002554

58.83

< 2.00E−16 ***

−28.827

< 2.00E−16 ***

x4

−0.09253

0.00321

x5

−0.00143

0.002231

x6

0.773287

−0.639**

Pr(>|t|)

Curation of Cancer-Related Genes

0.523*

0.002425

318.819

< 2.00E−16 ***

x7

−0.22529

0.005723

−39.362

< 2.00E−16 ***

x8

−0.03568

0.00451

−7.91

< 2.62E−15 ***

From the shortlist of DEGs, cancer-associated genes were curated
from OMIM (Online Mendelian Inheritance in Man) database
(www.ncbi.nlm.nih.gov/omim)2 and Cancer GeneticsWeb
database (www.cancer-genetics.org)3 to filter the significant
cancer-related genes. The roles of sorted genes in cancer were

Deviance Residuals: Min (−3.1894), 1Q (−0.0996), Median (0.0004), 3Q (0.1016), Max
(1.2137).
Signif. codes: 0 “***” 0.001 “**” 0.01 “*” 0.05 “.” 0.1 “ ” 1.
Number of Fisher Scoring iterations: 2.
Null deviance: 195495.4 on 54674 degrees of freedom.
Residual deviance: 1786.6 on 54666 degrees of freedom.

2 NCBI: http://www.ncbi.nlm.nih.gov/omim.

Accessed 2015-08.28.
Genetics Web: http://www.cancer-genetics.org/index.htm. Accessed at
Thursday Sep 10, 2016.
3 Cancer

TABLE 4 | The differentially expressed cancer-related genes curated from OMIM and Cancer Genetics. Web databases and their role has been referenced from PubMed.
S. no

Probe ID

Gene ID

Uniprot_ID

1

235737_at

TSLP

TSLP_HUMAN

2

205207_at

IL6

IL6_HUMAN

3

202269_x_at

GBP1

GBP1_HUMAN

4

227458_at

CD274

5

223501_at

6

7

Protein name

Reference links

Thymic stromal lymphopoietin

http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9CTSLP%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D

Interleukin-6

http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9CIL6%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D

26

Interferon-induced
guanylate-binding protein

http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9CGBP1%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D

PD1L1_HUMAN

430

Programmed cell death-1

http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9CCD274%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D

TNFSF13B

TN13B_HUMAN

68

Tumor necrosis factor ligand
superfamily member 13B

http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9CTNFSF13B%E2%80%9D+and+
%E2%80%9CCancer%E2%80%9D

210797_s_at

OASL

OASL_HUMAN

12

2′ -5′ -oligoadenylate synthase

http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9COASL%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D

220675_s_at

pnpla3

PLPL3_HUMAN

27

Patatin-like phospholipase
domain-c

http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9Cpnpla3%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D
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FIGURE 3 | Cluster analysis of 7 cancer-related DEGs with Euclidean distance (Binning method: Quantile). Green corresponds to a small distance and Red to a large
distance. Lines indicate the boundaries of the clusters in the level of the tree. Dotted lines indicate down or up-regulated genes.

evaluated through reported experimental studies using PubMed4
database.

2015). Therefore, the interacting partners of cancer-related
genes were assessed with a high confidence score (0.999) from
the STRING (Search Tool for the Retrieval of Interacting
Genes/Proteins) (Szklarczyk et al., 2011) and HAPPI (Human
Annotated and Predicted Protein Interaction) databases (Chen
et al., 2009), and PPI-network were constructed using Cytoscape
software (Cline et al., 2007) version 3.2.1. STRING and HAPPI
connect major databases and predict interactions based on
experiments, text mining and sequence homology. The role and
association of these genes (source and target) in cancer were
accessed from OMIM (www.omim.org), Cancer Genetics Web
(www.cancerindex.org) and National Cancer Database (www.
facs.org)5 . The relationships between source proteins and target
proteins (interacting proteins) were finally calculated.

Cluster and Functional Enrichment
Analysis of DEGs
We performed the cluster analysis (Eisen et al., 1998) based
on expression values in each sample to verify the variations in
gene expression levels between untreated and treated replicates.
The functional Annotation and pathway enrichment analysis
of cancer-related genes help us to reveal biological functions
(Nam and Kim, 2008; Muhammad et al., 2015), and it
was performed using the web-based DAVID (Database for
Annotation Visualization and Integrated Discovery) (Huang da
et al., 2009) and FunRich Annotation tools (Pathan et al., 2015).

De Novo Prediction of Regulatory Motifs

Construction of Protein-Protein Interaction
(PPI) Network
Proteins usually interact with each other to perform biological
functions (Li et al., 2004; Muhammad et al., 2014; Naz et al.,

To better understand the complex mechanisms of cancerrelated, differentially expressed genes controlling important
biological functions at transcriptional and post-transcriptional
levels, oPOSSUM web tool (Ho Sui et al., 2005) was used to

4 PubMed: http://www.ncbi.nlm.nih.gov/pubmed.

5 National
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Accessed 2015-08-28.

6

Cancer Database: http://www.facs.org. Accessed 2016-01.01.
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TABLE 5 | Functional and GO* analysis of 7-differentially expressed genes.
S.no

Term

Count

P-value

1
2

Fold enrichment

[GO:0006955] immune response

6

1.68E-05

13.1

[GO:0042129] regulation of T cell proliferation

3

5.69E-04

72.7

3

[GO:0050670] regulation of lymphocyte proliferation

3

0.001017

54.3

4

[GO:0070663] regulation of leukocyte proliferation

3

0.001041

53.7

5

[GO:0032944] regulation of mononuclear cell proliferation

3

0.001041

53.7

6

[GO:0050863] regulation of T cell activation

3

0.002007

38.5

7

[GO:0051249] regulation of lymphocyte activation

3

0.003188

30.5

8

[GO:0002694] regulation of leukocyte activation

3

0.003992

27.2

9

[GO:0050865] regulation of cell activation

3

0.004426

25.8

10

[GO:0005125] cytokine activity

3

0.004485

25.0

11

[GO:0050871] positive regulation of B cell activation

2

0.019354

91.1

12

[GO:0001776] leukocyte homeostasis

2

0.021097

83.5

13

[GO:0042102] positive regulation of T cell proliferation

2

0.022838

77.1

14

[GO:0050864] regulation of B cell activation

2

0.029772

58.9

15

[GO:0050671] positive regulation of lymphocyte proliferation

2

0.032074

54.7

16

[GO:0032946] positive regulation of mononuclear cell proliferation

2

0.032649

53.7

17

[GO:0070665] positive regulation of leukocyte proliferation

2

0.032649

53.7

18

[GO:0050870] positive regulation of T cell activation

2

0.044081

39.6

19

[GO:0002237] response to molecule of bacterial origin

2

0.049753

35.0

20

[GO:0051251] positive regulation of lymphocyte activation

2

0.055958

31.0

21

[GO:0048872] homeostasis of number of cells

2

0.057644

30.1

22

[GO:0002696] positive regulation of leukocyte activation

2

0.061008

28.4

23

[GO:0050867] positive regulation of cell activation

2

0.063803

27.1

24

[GO:0042127] regulation of cell proliferation

3

0.074923

5.7

25

[GO:0002252] immune effector process

2

0.076569

22.4

*GO, Gene Ontology.

paralleled by a declined total signal level. Increasing degrees
of saturation reduce the 3′ /5′ intensity gradient. The probe set
contained the target gene at a position near the 3′ end of the
corresponding transcripts. A side-by-side plot was produced
by the function plotAffyRNAdeg (Figure 2), and the function
summary of AffyRNAdeg produced a single summary statistic
for each array in the batch (Table 1), presenting an assessment
of the severity of RNA-degradation and significance level. We
focused to sort out important factors in the cDNA dataset such
as sequences biases, RNA degradation and quality of RNA to
ensure the reliability of the dataset to identify transcriptional
variations of the original samples. We standardized the sample
handling procedures through normalization and assessed the
optimal RNA reliability threshold using statistical and algorithm
discrimination measures.

identify the transcription factor (TF) binding sites and overrepresented regulatory motif of target matrices (Pavesi et al.,
2004) in promoter regions of expressed genes using default
parameters.

RESULTS
Microarray Analysis, Normalization, and
RNA Degradation Plots
The microarray data consists of 9-samples with 54675 probe
ids from a study of the effect of bacterial Shiga toxins on
human THP1 macrophage/monocytic cell lines (Leyva-Illades
et al., 2010). The AffyBatch object comprises the size of the
array 1,164 × 1,164 features with 54,675 affyids. Background
correction and normalization by quantile normalization were
completed to avoid systematic variation between samples. The
normalized probe-level data represents expression levels of
genes of entire DNA chip (Figure 1) involved in experimental
condition and individual probes in a probe set were ordered by
location relative to the 5′ end of the targeted RNA molecule.
The 3′ /5′ intensity gradient has been shown to depend on the
degree of competitive binding of specific and of non-specific
targets to a particular probe. Poor RNA quality is linked with
a reduced amount of RNA quantity hybridized to the array

Frontiers in Microbiology | www.frontiersin.org

Identifying Differentially Expressed Genes
(DEGs)
Our analyses revealed a total of 50 DEGs from Shiga effected
human THP1-monocytic cells between 03 untreated and 06
treated to replicate samples, including 01 up-regulated (2%)
and 49 down-regulated (98%) DEGs (Table 2). For generalized
linear models, the “cv.glm” function estimated the k–fold
cross-validation prediction error. The dispersion parameter for
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Gaussian is 0.03268, which indicates the confidence models.
The similar delta value of 0.032715 with 10 K-folds estimation
is obtained when we used the LOOCV method (during raw
cross-validation and then during adjusted cross-validation). The
significant codes (0.1, 0.01, 0.001, and 0.05) with minimum
deviance residuals are assessed (Table 3).

Cancer-related differentially expressed genes were used for overrepresentation and de novo analysis. Following transcription
factors (TF) class were found in these DEGs: REL, Stat, TRPCLUSTER, and bZIP. They are related to six target matrices in
the Jaspar core profile. Opossum-tool found RELA as a topranked matrix under both the Fisher-score (8.746e−02 ) and
the z-score (18.14) followed by the STAT1 which satisfied the
thresholds for significant over-representation (Figure 7). This
shows that genes containing conserved RELA, STATI, IRFI, NFkappaB, PEND, HLF, REL, CEBPA, DI_2, and NFKB1 binding
sites (Supplementary Figure 2) are indeed over-represented
in cancer-related DEGs and this over-representation can be
recuperated computationally. The rank of parameter settings for
the analysis of oPOSSUM-tool could reflect properties how a
specific TF controls its targets.

Identifying Cancer-Related Genes
Among differentially expressed genes, 7-cancer related genes
were obtained including TSLP, IL6, GBP1, CD274, TNFSF13B,
OASL, and pnpla3 after mapping (p < 0.00005) with OMIM
and Cancer Genetics Web database. The references to the role of
these genes in cancer have been shown in Table 4 using PubMed
database.

Cluster and Functional Enrichment
Analysis of DEGs
Clustering analysis has recognized to be helpful to understand
gene function, gene regulation, cellular processes, and subtypes
of cells. The cluster analysis of significantly expressed 7cancer related genes was studied with Euclidean distance
(Figure 3). The genetic expression of Shiga effected cell
samples is distinguished from the untreated replicates, indicating
that obvious differences existed between the two groups
(treated and untreated). The analysis showed that 6 downregulated and 1 up-regulated genes were significantly enriched.
The total number of enriched terms was calculated with
their significant cutoff parameters (Table 5). The immune
response (p < 1.68E-05), regulation of lymphocyte’s proliferation
(p < 0.001017), T-cell activation (p < 0.002007), cytokine
activity (p < 0.004485), leukocyte homeostasis (p < 0.021097)
and patatin-like phospholipase domain containing-3 were
expressively enriched among dysregulated genes. These gene
products are related to immune response system and signaling
pathways, signaling of chemical mediators and regulation of
a cell defense system (Figure 4A). The dysregulation of these
genes has been found associated with Kaposi sarcoma, cerebral
malformation, familial polyposis, and other clinical phenotypes
(Figure 4B).

DISCUSSION
Monocytes/macrophages are key cellular components of the
human immune system. Upon exposure to Shiga toxins produced
by Shigella dysenteriae serotype 1 and enterohaemorrhagic
Escherichia coli, these cells secrete chemical mediators, which
initiate in?ammation and activate of immune system signals
(Harrison et al., 2005). It has been known that Stx alters the
genetic expression and several signaling pathways triggered by
the toxin modify the expression of several genes in mammalian
cells. The comparative cDNA studies showed that Stx toxins
modulated the transcriptional response of human macrophagelike THP-1 cells (Leyva-Illades et al., 2010) associated with a
number of abnormalities. In another study, it was observed
that Stxs dysregulated the expression of Gb3/CD77 of lung
carcinoma cell lines (Uchida et al., 1999). Although it is known
that these toxins alter the genetic expression and affect the cellular
division and apoptosis pathway (Elmore, 2007), the underlying
mechanisms and its association with cancer development remain
unclear. The purpose of the current study was to investigate
differentially expressed genes of human THP1 cells in response to
Stxs and the association of these genes with cancer development.
In this study, we found 50 DEGs, and 49 of which were downregulated and only a single gene being up-regulated by Stxs.
Among these, 7-genes were mapped with cancer development
that fell into the following functional categories: Immune
response, regulation of lymphocyte’s proliferation, cytokine
activity and patatin-like phospholipase domain containing-3.
These DEGs are linked with important biological pathways
that are related to immune response signaling pathways,
signaling of chemical mediators and regulation of cell defense
system. Dysregulation of these genes can cause Kaposi sarcoma,
familial polyposis, and other clinical phenotypes. These findings
appear different from earlier microarray analyses performed by
Keepers et al. (2006), which revealed Stxs-encoded proteins with
functions related to transcriptional regulation, cell proliferation,
and cell cycle regulation. Cell proliferation, cell morphogenesis,
immune response signaling, anti-apoptosis, and regulation of
cell death are strongly associated with the down-regulated genes,

Protein-Protein Interaction Network
In PPI network, a total of 215 nodes was retrieved from
STRING and HAPPI databases. In this network, IL6_Human
as a source protein is connected with a number of target
proteins (interactors) (28%) that have been reported in several
cancers followed by the PD1L1_HUMAN (7%) (Figure 5).
Overexpression of PLPL3_HUMAN is associated with 4% of
interactors that are responsible for various types of cancers.
It has been shown that IL6_HUMAN is involved in
the progression of several cancers, extremely responsible
for leukemia, breast cancer and lymphoma (Figure 6).
PD1L1_HUMAN has also been found the connection in a
number of cancer cases, including lung cancer, leukemia,
Hodgkin lymphoma, and head/neck cancers. The observed least
association of OASL_HUMAN is with lymphoma and skin
cancer cases.

Frontiers in Microbiology | www.frontiersin.org
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FIGURE 4 | Functional enrichment analysis of expressively cancer-related DEGs using FunRich annotation tool (A) Biological pathways analysis (B) clinical
phenotypes for GEGs.

and to affect cytokine expression via several mechanisms,
including the activation of MAPK cascades leading to increased
cytokine gene transcriptional activity and improved translation
initiation efficiency (Harrison et al., 2005). However, in our
analysis, we found that Stxs down-regulated IL6 gene, which
is a potent inducer of the acute phase response and plays
an important role in the final differentiation of B-cells into

whereas cell cycle process, glycerolipid metabolism, and Patatinlike phospholipase activity are enriched in the up-regulated
genes. These factors are known to cancer progression (Hunter
and Pines, 1994; DeRisi et al., 1996).
Stxs have been reported to up-regulate the expression
of cytokines and chemokines from human primary blood
monocytes and to transform monocytic cell lines in vitro,

Frontiers in Microbiology | www.frontiersin.org
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FIGURE 5 | Protein-Protein Interaction network of cancer-related differential expressed genes. Each node represents the protein, while lines indicate the interaction
edges. The association of these source proteins and their interactors (target proteins) in cancers are shown in a bar graph. Blue and red color indicate down and
up-regulated genes, respectively.

Ig-secreting cells responsible for lymphocyte and monocyte
differentiation (Hirano et al., 1986). The downregulation of
IL-6 and other DEGs is associated with highly malignant
mammary carcinomas (Fontanini et al., 1999). Some genes
such as MMP11 (extra-cellular matrix proteins), XRCC1 (DNA
repair), VEGF (regulator of angiogenesis), Cyclin D1 (cell cycle
regulators) and tumor-suppressor genes (Semaphorin 3B, WNT5A) have been found as down-regulated genes during lung cancer
progression (Campioni et al., 2008). Recently it has studied that
Stxs elicit a proinflammatory response, including the elevated
production of TNF-α, IL-1β, IL-8, IL-6, and growth-related
oncogene α (Groα) both in vitro and in vivo (Lee et al., 2013).
Furthermore, our analysis reveals that toxin may affect IL6expression via a number of mechanisms, including JAK-STAT
cascade, cytosolic DNA-sensing, TNF signaling pathway and
transcriptional misregulation in cancer cells. IL6 is associated
with the progression of multiple cancers, including leukemia,
lymphoma, breast cancer, kidney, and lungs cancer. TNFSF13B
encodes Tumor Necrosis Factor (Ligand) Superfamily, Member
13b, also referred to as B-Cell-Activating Factor. It is important
in the proliferation and differentiation of B-cells that can act
as a transcription factor for its own gene in association with
NF-κB p50 (Yu et al., 2000). Similarly, CD274 is another
gene that is involved in the co-stimulatory signal, essential
for T-cell proliferation and production of IL10 and IFNG.
The dysregulation of this gene inhibits T-cell proliferation and

Frontiers in Microbiology | www.frontiersin.org

cytokine production causing a number of cancer including lung,
leukemia, Hodgkin lymphoma, and head/neck cancers (Dong
et al., 1999). We found cytokines and chemokines, including
IL-8, CSF2, GRO-1, GRO-2, and GRO-3, are affected by toxin
exposure (Leyva-Illades et al., 2010). In addition, expression
of TSLP, IL6, GBP1, CD274, TNFSF13B, OASL, and pnpla3
involved in the immune system, cell cycle, T-cell activation and
lymphocyte’s proliferation were also altered in THP1 cells by
toxin treatment. Dysregulation of these genes cause increased
apoptosis, cellular division and cancerous activities (Dong et al.,
1999; Andreoli et al., 2014; Barooei et al., 2015; Hengeveld
and Kersten, 2015; Ibsen et al., 2015; Manda et al., 2015; Ali
et al., 2016). We performed motif enrichment to predict the
transcription factor binding sites and over-represented regions
of these cancer-related genes to better understand the complex
biological mechanism. Several motifs, including RELA, STATI,
IRFI, NF-kappaB, PEND, HLF, REL, CEBPA, DI_2, and NFKB1
were found in the gene set for factors that play critical roles in
modeling required for immune response system, cellular cycles,
chemical mediation and cell growth.
It should be noted that the publicly accessible microarray
dataset studied here were subjected to rigorous statistical
algorithms. Thus, there is a high level of confidence in the list
of differentially expressed genes altered by Stxs. The present
study did not evaluate an independent prognostic factor but
suggest that differentially expressed genes should be evaluated as
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FIGURE 6 | The role of 7 DEGs in various cancers with Absolute Pearson correlation. Red color indicates the maximum involvement of a gene in various cancers and
Blue color represents the least association. This association was curated using OMIM, Cancer Genomic Web, and PubMed databases.

FIGURE 7 | Over-representation of cancer-related DEGs using oPOSSUM with 80% Matrix score.
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CONCLUSION
This study identified differentially expressed genes in human
THP1-monocytic cells upon treatment by bacterial Shiga toxins,
and many of these genes are involved in the pathophysiological
carcinomas. Stxs not only inhibited the protein synthesis
of target cells but even induce the genetic expression and
activate the multiple signaling pathways. Thus, cells treated
with Stxs may lead to progression of multiple cancers. These
findings may provide a valuable framework for developing
diagnostic biomarkers and treatment strategies for cancer.
Further molecular and real-time studies are warranted to
investigate the role of the identified genetic elements in cancer
development.
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SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fmicb.
2018.00380/full#supplementary-material
Supplementary Figure 1 | Framework our study indicates the effects of Shiga
toxins on cancer progressions.
Supplementary Figure 2 | Transcription factor binding sites (TFBS) of
cancer-related differentially expressed genes with their Jaspar core profiles. Top
10% of conserved regions (min. conservation 70%) are using oPOSSUM tool.

11

March 2018 | Volume 9 | Article 380

Muhammad et al.

Effect of Stxs on Cancer Progression

REFERENCES

Fraser, M. E., Chernaia, M. M., Kozlov, Y. V., and James, M. N. G. (1994). Crystal
structure of the holotoxin from Shigella dysenteriae at 2.5 Å resolution. Nat.
Struct. Biol. 1, 59–64. doi: 10.1038/nsb0194-59
Friedman, D. I., and Court, D. L. (2001). Bacteriophage lambda: alive
and well and still doing its thing. Curr. Opin. Microbiol. 4, 201–207.
doi: 10.1016/S1369-5274(00)00189-2
Fujita, A., Sato, J. R., de Rodrigues Lde, O., Ferreira, C. E., and Sogayar, M.
C. (2006). Evaluating different methods of microarray data normalization. B
Bioinformatics 7:469. doi: 10.1186/1471-2105-7-469
Harrison, L. M., van den Hoogen, C., van Haaften, W. C., and Tesh, V. L.
(2005). Chemokine expression in the monocytic cell line THP-1 in response to
purified Shiga toxin 1 and/or lipopolysaccharides. Infect. Immun. 73, 403–412.
doi: 10.1128/IAI.73.1.403-412.2005
Hattori, T., Watanabe-Takahashi, M., Shiina, I., Ohashi, Y., Dan, S., Nishikawa, K.,
et al. (2016). M-COPA, a novel Golgi system disruptor, suppresses apoptosis
induced by Shiga toxin. Genes Cells 21, 901–906. doi: 10.1111/gtc.12386
Hengeveld, P. J., and Kersten, M. J. (2015). B-cell activating factor in the
pathophysiology of multiple myeloma: a target for therapy? Blood Cancer J.
5:e282. doi: 10.1038/bcj.2015.3
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T.,
et al. (1986). Complementary DNA for a novel human interleukin (BSF-2)
that induces B lymphocytes to produce immunoglobulin. Nature 324, 73–76.
doi: 10.1038/324073a0
Ho Sui, S. J., Mortimer, J. R., Arenillas, D. J., Brumm, J., Walsh, C. J., Kennedy,
B. P., et al. (2005). oPOSSUM: identification of over-represented transcription
factor binding sites in co-expressed genes. Nuc. Acids Res. 33, 3154–3164.
doi: 10.1093/nar/gki624
Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009). Systematic and
integrative analysis of large gene lists using DAVID bioinformatics resources.
Nat. Protoc. 4, 44–57. doi: 10.1038/nprot.2008.211
Hunter, T., and Pines, J. (1994). Cyclins and cancer II: cyclin D and CDK
inhibitors come of age. Cell 79, 573–582. doi: 10.1016/0092-8674(94)90
543-6
Ibsen, M. S., Gad, H. H., Andersen, L. L., Hornung, V., Julkunen, I., Sarkar, S.
N., et al. (2015). Structural and functional analysis reveals that human OASL
binds dsRNA to enhance RIG-I signaling. Nuc. Acids Res. 43, 5236–5248.
doi: 10.1093/nar/gkv389
Keepers, T. R., Psotka, M. A., Gross, L. K., and Obrig, T. G. (2006). A murine
model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage
and physiologic response of human disease. J. Am. Soc. Nephrol. 17, 3404–3414.
doi: 10.1681/ASN.2006050419
Lee, M. S., Kim, M. H., and Tesh, V. L. (2013). Shiga toxins expressed by human
pathogenic bacteria induce immune responses in host cells. J. Microbiol. 51,
724–730. doi: 10.1007/s12275-013-3429-6
Leyva-Illades, D., Cherla, R. P., Galindo, C. L., Chopra, A. K., and Tesh, V. L.
(2010). Global transcriptional response of macrophage-like THP-1 cells to shiga
toxin type 1. Infect. Immun. 78, 2454–2465. doi: 10.1128/IAI.01341-09
Li, F., Long, T., Lu, Y., Ouyang, Q., and Tang, C. (2004). The yeast cell-cycle
network is robustly designed. Proc. Natl. Acad. Sci. U.S.A. 101, 4781–4786.
doi: 10.1073/pnas.0305937101
Lingwood, C. A. (2003). “Shiga toxin receptor glycolipid binding. Pathology and
utility,” in Methods in Molecular Medicine E. coli Shiga Toxin Methods and
Protocols, Vol. 73, eds D. Philpott and F. Ebel (Totowa, NJ: Humana Press, Inc.),
165–186.
Lingwood, C. A., Binnington, B., Manis, A., and Branch, D. R.
(2010). Globotriaosyl ceramide receptor function—where membrane
structure and pathology intersect. FEBS Lett. 584, 1879–1886.
doi: 10.1016/j.febslet.2009.11.089
Lukyanenko, V., Malyukova, I., Hubbard, A., Delannoy, M., Boedeker, E., Zhu,
C., et al. (2011). Enterohemorrhagic Escherichia coli infection stimulates Shiga
toxin-1 macropinocytosis and transcytosis across intestinal epithelial cells. Am.
J. Physiol. Cell Physiol. 301, C1140–C1149. doi: 10.1152/ajpcell.00036.2011
Malyukova, I., Murray, K. F., Zhu, C., Boedeker, E., Kane, A., Patterson, K., et al.
(2009). Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial
cells and transcellular transcytosis. Am. J. Physiol. Gastrointest. Liver Physiol.
296, G78–G92. doi: 10.1152/ajpgi.90347.2008

Affymetrix (1999). Affymetrix Microarray Suite User Guide, 4th Edn. Santa Clara,
CA: Affymetrix.
Affymetrix (2001). Affymetrix Microarray Suite User Guide, 5th Edn. Santa Clara,
CA: Affymetrix.
Ali, M., Yopp, A., Gopal, P., Beg, M. S., Zhu, H., Lee, W., et al. (2016). A variant in
PNPLA3 associated with fibrosis progression but not hepatocellular carcinoma
in patients with hepatitis C virus infection. Clin. Gastroenterol. Hepatol. 14,
295–300. doi: 10.1016/j.cgh.2015.08.018
Andreoli, M., Persico, M., Kumar, A., Orteca, N., Kumar, V., Pepe, A., et al. (2014).
Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications
for the development of a new class of anticancer agents against paclitaxel
resistant cancer cells. J. Med. Chem. 57, 7916–7932. doi: 10.1021/jm5009902
Barooei, R., Mahmoudian, R. A., Abbaszadegan, M. R., Mansouri, A., and
Gholamin, M. (2015). Evaluation of thymic stromal lymphopoietin (TSLP) and
its correlation with lymphatic metastasis in human gastric cancer. Med. Oncol.
32:217. doi: 10.1007/s12032-015-0653-4
Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: a
practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat.
Methodol. 57, 289–300.
Beutin, L. (2006). Emerging enterohaemorrhagic Escherichia coli, causes and effects
of the rise of a human pathogen. J. Vet. Med. B Infect. Dis. Vet. Public Health
53, 299–305. doi: 10.1111/j.1439-0450.2006.00968.x
Bolstad, B. M., Irizarry, R. A., Astrand, M., and Speed, T. P. (2003). A
comparison of normalization methods for high density oligonucleotide
array data based on variance and bias. Bioinformatics 19, 185–193.
doi: 10.1093/bioinformatics/19.2.185
Brandelli, J. R., Griener, T. P., Laing, A., Mulvey, G., and Armstrong, G. D. (2015).
The effects of shiga Toxin 1, 2 and their subunits on cytokine and chemokine
expression by human macrophage-like THP-1 cells. Toxins 7, 4054–4066.
doi: 10.3390/toxins7104054
Campioni, M., Ambrogi, V., Pompeo, E., Citro, G., Castelli, M., Spugnini, E.
P., et al. (2008). Identification of genes down-regulated during lung cancer
progression: a cDNA array study. J. Experiment. Clinic. Cancer Res. 27:38.
doi: 10.1186/1756-9966-27-38
Chao, A. W., Bhatti, M., DuPont, H. L., Nataro, J. P., Carlin, L. G., and Okhuysen,
P. C. (2017). Clinical features and molecular epidemiology of diarrheagenic
Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic
acid amplification in patients with cancer and diarrhea. Diagn. Microbiol. Infect.
Dis. 89, 235–240. doi: 10.1016/j.diagmicrobio.2017.08.004
Chen, J. Y., Mamidipalli, S., and Huan, T. (2009). HAPPI: an online database
of comprehensive human annotated and predicted protein interactions. BMC
Genomics 10:S16. doi: 10.1186/1471-2164-10-S1-S16
Cline, M. S., Smoot, M., Cerami, E., Kuchinsky, A., Landys, N., Workman, C.,
et al. (2007). Integration of biological networks and gene expression data using
cytoscape. Nat. Protoc. 2, 2366–2382. doi: 10.1038/nprot.2007.324
DeRisi, J., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., et al.
(1996). Use of a cDNA microarray to analyse gene expression patterns in
human cancer. Nat. Genet. 14, 457–460. doi: 10.1038/ng1296-457
DesRochers, T. M., Kimmerling, E. P., Jandhyala, D. M., El-Jouni, W., Zhou, J.,
Thorpe, C. M., et al. (2015). Effects of shiga toxin type 2 on a bioengineered
three-dimensional model of human renal tissue. Infect. Immun. 83, 28–38.
doi: 10.1128/IAI.02143-14
Dong, H., Zhu, G., Tamada, K., and Chen, L. (1999). B7-H1, a third member of the
B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat.
Med. 5, 1365–1369. doi: 10.1038/70932
Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998). Cluster analysis
and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A.
95, 14863–14868. doi: 10.1073/pnas.95.25.14863
Elmore, S. (2007). Apoptosis: a review of programmed cell death. Toxicol. Pathol.
35, 495–516. doi: 10.1080/01926230701320337
Fontanini, G., Campani, D., Roncella, M., Cecchetti, D., Calvo, S., Toniolo,
A., et al. (1999). Expression of interleukin 6 (IL-6) correlates with estrogen
receptor in human breast carcinoma. British J. Cancer. 80, 579–584.
doi: 10.1038/sj.bjc.6690394

Frontiers in Microbiology | www.frontiersin.org

12

March 2018 | Volume 9 | Article 380

Muhammad et al.

Effect of Stxs on Cancer Progression

Stricklett, P. K., Hughes, A. K., Ergonul, Z., and Kohan, D. E. (2002).
Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1
cytotoxicity and globotriaosylceramide expression. J. Infect. Dis. 186, 976–982.
doi: 10.1086/344053
Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M., Roth, A., Minguez, P.,
et al. (2011). The STRING database in 2011: functional interaction networks
of proteins, globally integrated and scored. Nucleic Acids Res. 39, D561–D568.
doi: 10.1093/nar/gkq973
Tesh, V. L. (2010). Induction of apoptosis by Shiga toxins. Future Microbiol. 5,
431–453. doi: 10.2217/fmb.10.4
Thorpe, C. M., Smith, W. E., Hurley, B. P., and Acheson, D. W. (2001). Shiga toxins
induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in
intestinal epithelial cells, resulting in increased chemokine expression. Infect.
Immun. 69, 6140–6147. doi: 10.1128/IAI.69.10.6140-6147.2001
Todar, K. (2007). Pathogenic E. coli. Online Textbook of Bacteriology. University
of Wisconsin-Madison Department of Bacteriology. Cornell University, Ithaca,
New York, NY.
Torgersen, M. L., Engedal, N., Bergan, J., and Sandvig, K. (2010).
The intracellular journey of shiga toxins. Open Toxinol. J. 3, 3–12.
doi: 10.2174/1875414701003020003
Troyanskaya, O., Cantor, M., Sherlock, G., Brown, P., Hastie, T., Tibshirani,
R., et al. (2001). Missing value estimation methods for DNA microarrays.
Bioinformatics 17, 520–525. doi: 10.1093/bioinformatics/17.6.520
Tusher, V. G., Tibshirani, R., and Chu, G. (2001). Significance analysis of
microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci.
U.S.A. 98, 5116–5121. doi: 10.1073/pnas.091062498
Uchida, H., Kiyokawa, N., Taguchi, T., Horie, H., Fujimoto, J., and Takeda, T.
(1999). Shiga toxins induce apoptosis in pulmonary epithelium-derived cells.
J. Infec. Diseas. 180, 1902–1911. doi: 10.1086/315131
van de Kar, N. C., Monnens, L. A., Karmali, M. A., and van Hinsbergh, V.
W. (1992). Tumor necrosis factor and interleukin-1 induce expression of
the verocytotoxin receptor globotriaosylceramide on human endothelial cells:
implications for the pathogenesis of the hemolytic-uremic syndrome. Blood 80,
2755–2764.
Vogt, R. L., and Dippold, L. (2005). Escherichia coli O157:H7 outbreak associated
with consumption of ground beef, June–July 2002. Public Health Rep. 120,
174–178. doi: 10.1177/003335490512000211
World Health Organization (2016). Diarrheal Diseases: Shigellosis. Initiative
for Vaccine Research (IVR). New York, NY: World Health Organization
(Accessed August 4, 2016).
Yoon, D., Yi, S. G., Kim, J. H., and Park, T. (2004). Two-stage normalization using
background intensities in cDNA microarray data. BMC Bioinformatics 5:97.
doi: 10.1186/1471-2105-5-97
Yu, G., Boone, T., Delaney, J., Hawkins, N., Kelley, M., Ramakrishnan, M.,
et al. (2000). APRIL and TALL-I and receptors BCMA and TACI: system for
regulating humoral immunity. Nat. Immunol. 1, 252–256. doi: 10.1038/79802

Manda, K. R., Tripathi, P., His, A. C., Ning, J., Ruzinova, M. B., Liapis, H.,
et al. (2015). NFATc1 promotes prostate tumorigenesis and overcomes PTEN
loss-induced senescence. Oncogene 35, 3282–3292. doi: 10.1038/onc.2015.389
Melton-Celsa, A. R. (2014). Shiga toxin (Stx) classification, structure, and function.
Microbiol. Spectr. 2, 1–20. doi: 10.1128/microbiolspec.EHEC-0024-2013
Mims, C. A., Playfair, J. H. L., Roitt, I. M., Williams, W. (1993). Medical
Microbiology, 1st Edn. Mosby, MO: Cambridge University Press.
Muhammad, S. A., Ahmed, S., Ali, A., Huang, H., Wu, X., Yang, X.
F., et al. (2014). Prioritizing drug targets in Clostridium botulinum
with a computational systems biology approach. Genomics 104, 24–35.
doi: 10.1016/j.ygeno.2014.05.002
Muhammad, S. A., Fatima, N., Syed, N.-I-H., Wu, X., Yang, X. F., and
Chen, J. Y. (2015). MicroRNA expression profiling of human respiratory
epithelium affected by invasive Candida infection. PLoS ONE 10:e0136454.
doi: 10.1371/journal.pone.0136454
Nam, D., and Kim, S. Y. (2008). Gene-set approach for expression pattern analysis.
Brief. Bioinformatics 9, 189–197. doi: 10.1093/bib/bbn001
Naz, A., Awan, F. M., Obaid, A., Muhammad, S. A., Paracha, R. Z., Ahmad, J., et al.
(2015). Identification of putative vaccine candidates against Helicobacter pylori
exploiting exoproteome and secretome: a reverse vaccinology based approach.
Infec. Genet. Evol. 32, 280–291. doi: 10.1016/j.meegid.2015.03.027
NCBI (2015). NCBI: http://www.ncbi.nlm.nih.gov/gene/3624. Accessed August 29,
2015.
Obenchain, V., Lawrence, M., Carey, V., Gogarten, S., Shannon, P., and
Morgan, M. (2014). Variant annotation: a bioconductor package for
exploration and annotation of genetic variants. Bioinformatics 30, 2076–2078.
doi: 10.1093/bioinformatics/btu168
Pathan, M., Keerthikumar, S., Ang, C. S., Gangoda, L., Quek, C. M. J., Williamson,
N. J., et al. (2015). FunRich: a standalone tool for functional enrichment
analysis. Proteomics 15, 2597–2601. doi: 10.1002/pmic.201400515
Pavesi, G., Mereghetti, P., Mauri, G., and Pesole, G. (2004). Weeder web:
discovery of transcription factor binding sites in a set of sequences from
co-regulated genes. Nucleic Acids Res. 32, W199–W203. doi: 10.1093/nar/
gkh465
Ramegowda, B., Samuel, J. E., and Tesh, V. L. (1999). Interaction of Shiga toxins
with human brain microvascular endothelial cells: cytokines as sensitizing
agents. J. Infect. Dis. 180, 1205–1213. doi: 10.1086/314982
Ripley, B. (2010). Package ‘Boot’. Available online at: CRAN: http://cran.rproject.
org/web/packages/boot/index.html (Accessed September 10, 2015).
Ryoo, H. D., and Bergmann, A. (2012). The role of apoptosis-induced proliferation
for regeneration and cancer. Cold Spring Harb. Perspect. Biol. 4:a008797.
doi: 10.1101/cshperspect.a008797
Sandvig, K., Bergan, J., Dyve, A., Skotland, T., and Torgersen, M. L. (2010).
Endocytosis and retrograde transport of Shiga toxin. Toxicon 56, 1181–1185.
doi: 10.1016/j.toxicon.2009.11.021
Sandvig, K., Grimmer, S., Lauvrak, S. U., Torgersen, M. L., Skretting, G.,
van Deurs, B., et al. (2002). Pathways followed by ricin and Shiga toxin
into cells. Histochem. Cell Biol. 117, 131–141. doi: 10.1007/s00418-0010346-2
Schweppe, C. H., Bielaszewska, M., Pohlentz, G., Friedrich, A. W., Büntemeyer,
H., Schmidt, M. A., et al. (2008). Glycosphingolipids in vascular endothelial
cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression
with differential Shiga toxin 1 cytotoxicity. Glycoconj. J. 25, 291–304.
doi: 10.1007/s10719-007-9091-7
Seymour, G. (1993). Predictive Inference. New York, NY: Chapman and Hall.
Spears, K. J., Roe, A. J., and Gally, D. L. (2006). A comparison of enteropathogenic
and enterohaemorragic E. coli pathogenesis. FEMS Microbiol. Lett. 255,
187–202. doi: 10.1111/j.1574-6968.2006.00119.x

Frontiers in Microbiology | www.frontiersin.org

Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Muhammad, Guo, Nguyen, Wu, Bai, Yang and Chen. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.

13

March 2018 | Volume 9 | Article 380

